Cái chết tế bào phát triển trong hệ thống nigrostriatal

Akerud P, Alberch J, Eketjall S, Wagner J, Arenas E (1999) Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons. J Neurochem 73:70–78 Alexi T, Hefti F (1993) Trophic actions of transforming growth factor α on mesencephalic dopaminergic neurons developing in culture. Neuroscience 55:903–918 Alonso-Vanegas MA, Fawcett JP, Causing CG, Miller FD, Sadikot AF (1999) Characterization of dopaminergic midbrain neurons in a DBH:BDNF transgenic mouse. J Comp Neurol 413:449–462 Altar CA, DiStefano PS (1998) Neurotrophin trafficking by anterograde transport. Trends Neurosci 21:433–437 Altar CA, Boylan CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C (1994) Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. J Neurochem 63:1021–1032 Barde YA (1989) Trophic factors and neuronal survival. Neuron 2:1525–1534 Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549–553 Beck KD, Irwin I, Valverde J, Brennan T, Langston JW, Hefti F (1996) GDNF induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron 16:665–673 Blum M (1998) A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra. Nat Neurosci 1:374–377 Blum M, Weickert CS (1995) GDNF mRNA expression in normal postnatal development, aging, and in weaver mutant mice. Neurobiol Aging 16:925–929 Burke RE, Macaya A, DeVivo D, Kenyon N, Janec EM (1992) Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons. Neuroscience 50:559–569 Burke RE, Antonelli M, Sulzer D (1998) Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture. J Neurochem 71:517–525 Cacalano G, Farinas I, Wang LC, Hagler K, Forgie A, Moore M, Armanini M, Phillips H, Ryan AM, Reichardt LF, Hynes M, Davies A, Rosenthal A (1998) GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 21:53–62 Cho J, Kholodilov NG, Burke RE (2003) The developmental time course of glial cell line-derived neurotrophic factor (GDNF) and GDNF receptor alpha-1 mRNA expression in the striatum and substantia nigra. Ann NY Acad Sci 991:284–287 Cho J, Kholodilov NG, Burke RE (2004) Patterns of developmental mRNA expression of neurturin and GFRalpha2 in the rat striatum and substantia nigra do not suggest a role in the regulation of natural cell death in dopamine neurons. Brain Res Dev Brain Res 148:143–149 Choi-Lundberg DL, Bohn MC (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Dev Brain Res 85:80–88 Chun HS, Yoo MS, DeGiorgio LA, Volpe BT, Peng D, Baker H, Peng C, Son JH (2002) Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor. Exp Neurol 173:235–244 Clarke PGH (1985) Neuronal death in the development of the vertebrate nervous system. Trends Neurosci 8:345–349 Clarke PGH (1990) Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 181:195–213 Clarke PGH, Oppenheim RW (1995) Neuron death in vertebrate development: in vivo methods. In: Schwartz LM, Osborne BA (eds) Methods in cell biology: cell death. Academic, New York, pp 277–321 Coyle JT (1977) Biochemical aspects of neurotransmission in the developing brain. Int Rev Neurobiol 20:65–102 Coyle JT, Schwarcz R (1976) Lesion of striatal neurones with kainic acid provides a model for Huntington’s chorea. Nature 263:244–246 El-Khodor BF, Burke RE (2002) Medial forebrain bundle axotomy during development induces apoptosis in dopamine neurons of the substantia nigra and activation of caspases in their degenerating axons. J Comp Neurol 452:65–79 Enomoto H, Araki T, Jackman A, Heuckeroth RO, Snider WD, Johnson EMJ, Milbrandt J (1998) GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 21:317–324 Freeman RS, Estus S, Johnson EM (1994) Analysis of cell cycle related gene expression in postmitotic neurons selective induction of cyclin D1 during programmed cell death. Neuron 12:343–355 Gallyas F, Wolff JR, Bottcher H, Zaborsky L (1980) A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Tech 55:299–306 Ganguly A, Oo TF, Rzhetskaya M, Pratt R, Yarygina O, Momoi T, Kholodilov N, Burke RE (2004) CEP11004, a novel inhibitor of the mixed lineage kinases, suppresses apoptotic death in dopamine neurons of the substantia nigra induced by 6-hydroxydopamine. J Neurochem 88:469–480 Golden JP, DeMaro JA, Osborne PA, Milbrandt J, Johnson EMJ (1999) Expression of neurturin, GDNF, and GDNF family-receptor mRNA in the developing and mature mouse. Exp Neurol 158:504–528 Groc L, Bezin L, Jiang H, Jackson TS, Levine RA (2001) Bax, Bcl-2, and cyclin expression and apoptosis in rat substantia nigra during development. Neurosci Lett 306:198–202 Groc L, Jackson HT, Jiang H, Bezin L, Koubi D, Corcoran GB, Levine RA (2002) Nitric oxide synthase inhibition during development: effect on apoptotic death of dopamine neurons. Brain Res Dev Brain Res 138:147–153 Hattori T, McGeer PL (1973) Synaptogenesis in the corpus striatum of infant rat. Exp Neurol 38:70–79 Hemmendinger LM, Garber BB, Hoffmann PC, Heller A (1981) Target neuron-specific process formation by embryonic mesencephalic dopamine neurons in vitro. Proc Natl Acad Sci USA 78:1264–1268 Herrup K, Sunter K (1987) Numerical matching during cerebellar development: quantitative analysis of granule cell death in staggerer mouse chimeras. J Neurosci 7:829–836 Hoffmann PC, Hemmendinger LM, Kotake C, Heller A (1983) Enhanced dopamine cell survival in reaggregates containing target cells. Brain Res 274:275–281 Horger BA, Nishimura MC, Armanini MP, Wang LC, Poulsen KT, Rosenblad C, Kirik D, Moffat B, Simmons L, Johnson EJ, Milbrandt J, Rosenthal A, Björklund A, Vandlen RA, Hynes MA, Phillips HS (1998) Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci 18:4929–4937 Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230–232 Jackson-Lewis V, Vila M, Djaldetti R, Guegan C, Liberatore G, Liu J, O’Malley KL, Burke RE, Przedborski S (2000) Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 424:476–488 Janec E, Burke RE (1993) Naturally occurring cell death during postnatal development of the substantia nigra of the rat. Mol Cell Neurosci 4:30–35 Jeon BS, Kholodilov NG, Oo TF, Kim S, Tomaselli KJ, Srinivasan A, Stefanis L, Burke RE (1999) Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. J Neurochem 73:322–333 Kalsbeek A, Voorn P, Buijs RM (1992) Development of dopamine-containing systems in the CNS. In: Björklund A, Hokfelt T, Tohyama M (eds) Handbook of chemical neuroanatomy, vol 10. Ontogeny of transmitters and peptides in the CNS. Elsevier, Amsterdam, pp 63–112 Kelly WJ, Burke RE (1996) Apoptotic neuron death in rat substantia nigra induced by striatal excitotoxic injury is developmentally dependent. Neurosci Lett 220:85–88 Kholodilov N, Yarygina O, Oo TF, Zhang H, Sulzer D, Dauer WT, Burke RE (2004) Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets. J Neurosci 24:3136–3146 Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132–1136 Knusel B, Beck KD, Winslow JW, Rosenthal A, Burton LE, Widmer HR, Nikolics K, Hefti F (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12:4391–4402 Kotzbauer PT, Lampe PA, Heuckeroth RO, Golden JP, Creedon DJ, Johnson EMJ, Milbrandt J (1996) Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 384:467–470 Krammer EB (1980) Anterograde and transsynaptic degeneration “en cascade” in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington’s disease. Brain Res 196:209–221 Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F (1993) Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection. Neuroscience 53:639–650 Lauder JM, Bloom FE (1975) Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. J Comp Neurol 163:251–264 Lazar LM, Blum M (1992) Regional distribution and developmental expression of epidermal growth factor and transforming growth factor-alpha mRNA in mouse brain by a quantitative nuclease protection assay. J Neurosci 12:1688–1697 Ledda F, Paratcha G, Ibanez CF (2002) Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5. Neuron 36:387–401 Leibrock J, Lottspeich F, Hohn A, Hofer M, Hengerer B, Masiakowski P, Thoenen H, Barde YA (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341:149–152 Lin L-FH, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130–1132 Linden R (1994) The survival of developing neurons: a review of afferent control. Neuroscience 58:671–682 Lindsay RM (1993) Brain-derived neurotrophic factor: an NGF-related neurotrophin. In: Loughlin SE, Fallon JH (eds) Neurotrophic factors. Academic Press, San Diego, pp 257–284 Lopez-Martin E, Caruncho HJ, Rodriguez-Pallares J, Guerra MJ, Labandeira-Garcia JL (1999) Striatal dopaminergic afferents concentrate in GDNF-positive patches during development and in developing intrastriatal striatal grafts. J Comp Neurol 406:199–206 Lundberg C, Wictorin K, Björklund A (1994) Retrograde degenerative changes in the substantia nigra pars compacta following an excitotoxic lesion of the striatum. Brain Res 644:205–212 Macaya A, Munell F, Gubits RM, Burke RE (1994) Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proc Natl Acad Sci USA 91:8117–8121 Maisonpierre PC, Belluscio L, Friedman B, Alderson RF, Wiegand SJ, Furth ME, Lindsay RM, Yancopoulos GD (1990) NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 5:501–509 Marchand R, Poirer LJ (1983) Isthmic origin of neurons of the rat substantia nigra. Neuroscience 9:373–381 Marti MJ, James CJ, Oo TF, Kelly WJ, Burke RE (1997) Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J Neurosci 17:2030–2039 Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274:1678–1683 Mehmet H (2000) Caspases find a new place to hide. Nature 403:29–30 Oiwa Y, Yoshimura R, Nakai K, Itakura T (2002) Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson’s disease. Brain Res 947:271–283 Oo TF, Burke RE (1997) The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Dev Brain Res 98:191–196 Oo TF, Blazeski R, Harrison SMW, Henchcliffe C, Mason CA, Roffler-Tarlov S, Burke RE (1996) Neuron death in the substantia nigra of weaver mouse occurs late in development and is not apoptotic. J Neurosci 16:6134–6145 Oo TF, Siman R, Burke RE (2002) Distinct nuclear and cytoplasmic localization of caspase cleavage products in two models of induced apoptotic death in dopamine neurons of the substantia nigra. Exp Neurol 175:1–9 Oo TF, Kholodilov N, Burke RE (2003) Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal GDNF in vivo. J Neurosci 23:5141–5148 Oppenheim RW (1991) Cell death during development of the nervous system. Ann Rev Neurosci 14:453–501 Paratcha G, Ledda F, Baars L, Coulpier M, Besset V, Anders J, Scott R, Ibanez CF (2001) Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29:171–184 Pasinetti GM, Morgan DG, Finch CE (1991) Disappearance of GAD-mRNA and tyrosine hydroxylase in substantia nigra following striatal ibotenic acid lesions: evidence for transneuronal regression. Exp Neurol 112:131–139 Pichel JG, Shen L, Sheng HZ, Granholm A-C, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73–76 Prochiantz A, Porzio U di, Kato A, Berger B, Glowinski J (1979) In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells. Proc Natl Acad Sci USA 76:5387–5391 Purves D, Lichtman JW (1985) Principles of neural development. Sinauer, Sunderland Raoul C, Henderson CE, Pettmann B (1999) Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J Cell Biol 147:1049–1062 Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, Pettmann B (2002) Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 35:1067–1083 Rayport S, Sulzer D, Shi WX, Sawasdikosol S, Monaco J, Batson D, Rajendran G (1992) Identified postnatal mesolimbic dopamine neurons in culture morphology and electrophysiology. J Neurosci 12:4264–4280 Saji M, Reis DJ (1987) Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science 235:66–68 Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 382:70–73 Schaar DG, Sieber BA, Dreyfus CF, Black IB (1993) Regional and cell specific expression of GDNF in rat brain. Exp Neurol 124:368–371 Scorrano L, Korsmeyer SJ (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 304:437–444 Stefanis L, Burke RE (1996) Transneuronal degeneration in substantia nigra pars reticulata following striatal excitotoxic injury in adult rat: time course, distribution, and morphology of cell death. Neuroscience 74:997–1008 Stromberg I, Björklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C (1993) Glial cell line derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401–412 Tepper JM, Damlama M, Trent F (1994) Postnatal changes in the distribution and morphology of rat substantia nigra dopaminergic neurons. Neuroscience 60:469–477 Tomac A, Widenfalk J, Lin LH, Kohno T, Ebendal T, Hoffer BJ, Olson L (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci USA 92:8274–8278 Tomozawa Y, Appel SH (1986) Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro. Brain Res 399:111–124 Treanor JJ, Goodman L, Sauvage F de, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A (1996) Characterization of a multicomponent receptor for GDNF. Nature 382:80–83 Vila M, Jackson-Lewis V, Vukosavic S, Djaldetti R, Liberatore G, Offen D, Korsmeyer SJ, Przedborski S (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease. Proc Natl Acad Sci USA 98:2837–2842 Wetts R, Herrup K (1983) Direct correlation between Purkinje and granule cell number in the cerebella of lurcher chimeras and wild-type mice. Dev Brain Res 10:41–47 Widenfalk J, Nosrat C, Tomac A, Westphal H, Hoffer B, Olson L (1997) Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J Neurosci 17:8506–8519 Wilcox JN, Derynck R (1988) Localization of cells synthesizing transforming growth factor-alpha mRNA in the mouse brain. J Neurosci 8:1901–1904 Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington’s disease. Cell 101:57–66 Yu T, Scully S, Yu Y, Fox GM, Jing S, Zhou R (1998) Expression of GDNF family receptor components during development: implications in the mechanisms of interaction. J Neurosci 18:4684–4696 Zinszner H, Kuroda M, Wang X, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D (1998) CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982–995